Erector Spinae Plane Block for Peri-operative Pain Management in Pediatric Open Pyeloplasty Cases

NCT ID: NCT03790566

Last Updated: 2019-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-20

Study Completion Date

2019-09-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Regional anesthesia decreases the need for intravenous analgesia in the peri-operative period. Erector spinae plane (ESP) and transversus abdominus plane (TAP) blocks are two common regional anesthesia techniques shown to be effective in open abdominal surgeries. We aim to compare effectiveness of ESP block with TAP block for peri-operative analgesia in pediatric open pyeloplasty patients with a flank incision.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Regional anesthesia for effective post-operative pain management is a part of the pediatric Enhanced Recovery After Surgery (ERAS) protocol. Epidural anesthesia is the gold standard for analgesia for open abdominal surgeries, however difficulties in application and possible complications deter clinicians from utilizing this method. Safe and effective alternatives to epidural anesthesia has been a critical and popular focus of clinical research in recent years. Transversus abdominus plane (TAP) block is an alternative technique shown to be effective in pediatric open abdominal surgeries.

Erector spinae plane (ESP) block was described as an effective block for multi-dermatome pain after thoracic surgery. It is emerging as a safe and easy-to-perform alternative to epidural anesthesia for pelvic, abdominal and thoracic surgery.

During an open pyeloplasty, the flank incision goes through the transversus abdominus plane, where the local anesthetic is injected for TAP block. This may weaken the analgesic effect of the block. In the ESP block, local anesthetic diffuses cranio-caudally through the fascia of erector spinae muscles and the flank incision does not disturb this plane. We aim to compare the effectiveness of ESP block with TAP block in open pyeloplasty patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia and Analgesia Pediatrics Urologic Surgical Procedures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector spinae plane block

With the patient in lateral decubitus position (surgical side up), the transverse processes of T10-T12 vertebrae and erector spinae (ES) fascia are visualized 1-2 cm lateral to the vertebral spine using a linear ultrasound probe. A 22G peripheral block needle is introduced with in-plane technique under the ES muscle and local anesthetic solution (0.5 ml/kg 0.25% bupivacaine) is injected in this plane after a test injection with 0.5 ml of 0.9% NaCl solution to visualize opening of ESP.

Group Type EXPERIMENTAL

Bupivacaine

Intervention Type DRUG

0.5 ml/kg 0.25% bupivacaine

Transversus abdominus plane block

With the patient in supine position, three layers of abdominal muscle are visualized using the linear ultrasound probe held with the long axis on the mid-axillary line above the iliac crest. 22G peripheral block needle is introduced in-plane into the fascia between the internal oblique and transversus abdominus muscles and local anesthetic solution (0.5 ml/kg 0.25% bupivacaine) is injected in this plane after a test injection with 0.5 ml of 0.9% NaCl solution to visualize opening of ESP.

Group Type ACTIVE_COMPARATOR

Bupivacaine

Intervention Type DRUG

0.5 ml/kg 0.25% bupivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine

0.5 ml/kg 0.25% bupivacaine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologist class I, II or III
* Patients scheduled for elective open pyeloplasty surgery

Exclusion Criteria

* Local anesthetic allergy or other contraindication to local anesthetic use
* Coagulation disorders
* History of chronic pain
* Patient/Family refusal
* History of scoliosis, spinae bifida, abdominal wall defect
* Past surgical procedures with abdominal wall incision
* Plan to extend the flank incision for additional surgical intervention
Minimum Eligible Age

1 Year

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aybike Onur Gonen

UNKNOWN

Sponsor Role collaborator

Ayse Cigdem Tutuncu

OTHER

Sponsor Role collaborator

Kaya, Guner, M.D.

INDIV

Sponsor Role collaborator

Rahsan Ozcan

UNKNOWN

Sponsor Role collaborator

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

pinar kendigelen

Assoc. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pinar Kendigelen, Assoc. Prof.

Role: PRINCIPAL_INVESTIGATOR

Istanbul University Cerrahpasa Medical Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University Cerrahpasa Medical Faculty

Istanbul, Please Select, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pinar Kendigelen, Assoc. Prof.

Role: CONTACT

+905325868734

Aybike Onur Gonen, MD

Role: CONTACT

+905322701086

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pinar Kendigelen, Assoc.Prof.

Role: primary

+905325868734

Aybike Onur Gonen, MD

Role: backup

+905322701086

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

72109855-604.01.01-53213

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.